Premium Nahrungsergänzungsmittel | artgerecht

Treat-to-Target: Medical Strategy Explained

Treat-to-Target is a medical treatment strategy in which therapy is consistently directed toward a clearly defined goal and adjusted until that target is achieved.

Regular tips about health Regular tips about health

Things worth knowing about "Treat-to-Target"

Treat-to-Target is a medical treatment strategy in which therapy is consistently directed toward a clearly defined goal and adjusted until that target is achieved.

What is Treat-to-Target?

Treat-to-Target (abbreviated T2T) is a medical management concept in which a patient's therapy is systematically directed toward achieving a pre-defined, measurable treatment goal. The treatment is continuously monitored and adjusted until that target is reached. The concept was originally developed in the management of diabetes mellitus but has since been adopted across many medical specialties, including rheumatology, cardiology, and gastroenterology.

Core Principles of the Treat-to-Target Strategy

The Treat-to-Target approach is built on three fundamental pillars:

Defining a clear treatment target: Before initiating therapy, a specific and measurable goal is established -- for example, a target HbA1c level in diabetes, a remission status in rheumatoid arthritis, or a target LDL cholesterol level in cardiology.
Regular monitoring and measurement: Treatment progress is assessed at defined intervals through clinical examinations, laboratory values, or imaging procedures.
Therapy adjustment: If the target is not reached, treatment is consistently modified -- for example, by increasing the dose, switching medications, or combining multiple agents.

Areas of Application

Rheumatology

In rheumatology, particularly in the management of rheumatoid arthritis, Treat-to-Target is now an established standard of care. The treatment goal is typically remission (complete resolution of disease signs) or at least a low disease activity state. Disease activity is regularly assessed using validated scoring tools such as the DAS28 (Disease Activity Score in 28 joints).

Diabetology

In the management of diabetes mellitus, the Treat-to-Target strategy aims to achieve an individually defined HbA1c target value. This value reflects the average blood glucose level over the past two to three months and is a key indicator of the risk of complications such as kidney damage, vision loss, and nerve injury.

Cardiology

In cardiology, Treat-to-Target is frequently applied in the management of elevated blood lipid levels. The goal is to achieve a specific LDL cholesterol target to reduce the risk of heart attack and stroke. Target values differ depending on the individual patient's cardiovascular risk profile.

Gastroenterology

In chronic inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, the Treat-to-Target strategy aims for both clinical and endoscopic remission. This means that not only symptoms should resolve, but also the signs of mucosal inflammation visible during colonoscopy.

Advantages of the Treat-to-Target Strategy

Improved long-term disease control and quality of life
Early therapy adjustment when treatment response is insufficient
Reduction of disease-related damage and complications
Transparency and clarity for both the patient and the treatment team
Encouragement of active patient involvement in the treatment process

Limitations and Challenges

Despite its many benefits, the Treat-to-Target concept also comes with challenges. Not all diseases have well-defined and universally accepted target values. Furthermore, treatment goals must be tailored to the individual patient, as age, comorbidities, and personal preferences play an important role. Close monitoring and regular therapy adjustments also require adequate resources within the healthcare system.

References

Smolen JS et al. - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 2023.
American Diabetes Association - Standards of Medical Care in Diabetes 2023. Diabetes Care, 2023; 46(Suppl. 1).
Peyrin-Biroulet L et al. - Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology, 2015; 110(9):1324-1338.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.